Hemp Industry Appeals To National Governments Over CBD Narcotic Classification

Hemp industry groups in France and Germany are separately appealing to their national governments to intervene in the European Commission's attempt to classify CBD as a narcotic rather than novel food.

Full spectrum Cannabidiol CBD oils, capsules and crystals isolate with small blackboard with CBD word and chemical structure on wooden backdrop - Image

Representatives of the French and German hemp industry have appealed to their respective national governments to intervene after the European Commission indicated it was considering classifying CBD as a narcotic.

More from Cannabis/CBD

Senate Hemp Regulation Bill’s Broad Prohibition On Synthetics In Supplements Has Industry Attention

 

Provision in Wyden and Merkley’s “Cannabinoid Safety and Regulation Act” referencing FDA authority outside hemp-derived ingredients could provide agency with needed authority to force from the market products labeled as supplements but containing drugs or eliminate the use of many safe ingredients in supplements.

Senate Hemp Regulation Bill Offers Option To House’s Blanket Limit On Levels Of All THCs

 

Democrats Wyden and Merkley author Cannabinoid Safety and Regulation Act to limit sales to consumers 21 and older and authorize FDA to order recalls and impose bans on cannabis products with dangerous chemicals or additives. It also would establish regulatory structure for using cannabinoids found naturally in hemp and allowing “semi-synthetic” ingredients while prohibiting artificial or fully synthetic cannabinoids.

Tobacco Giant Philip Morris Sells Medical Device Business, Keeps Consumer Health Footprint

 
• By 

Philip Morris described a scenario of being essentially blacklisted by the health care sector and its CDMO partners as it threw in the towel on its £1.1bn acquisition of UK inhalation specialist Vectura. It agreed to offload the firm at a fraction of the initial cost.

Dietary Supplements Category Ranks Second For Food Fraud In EU

 
• By 

Report from European Commission's Alert and Cooperation Network finds EU consumers are being deceived by companies marketing supplements making unauthorized health claims and containing unapproved ingredients. 

More from Ingredients & Safety

First UK CBD Novel Food Authorizations Expected In 2025

 
• By 

FSA now aims to send the first recommendations for the authorization of CBD novel food products to UK government ministers in 2025, according to its most recent board meeting. The agency is closely scrutinizing trace THC levels and is planning to ban use of CBD food products by under 18s.

Asia Pacific Expected To Account For Half Of Global Probiotics Sales This Year

 
• By 

Interest in probiotics in APAC is expected to continue to grow driven in part by the “K-food” (Korean food) wave, Euromonitor International reports.

EMA Clarifies Paracetamol Warnings On Risk Of Blood And Fluid Abnormality

 
• By 

EMA's PRAC clarifies risk of high anion gap metabolic acidosis (HAGMA) in users of OTC paracetamol with new package leaflet and SmPC warnings.